ENTITY
CanariaBio

CanariaBio (016790 KS)

53
Analysis
Consumer Staples • South Korea
CANARIABIO Inc. operates as a new anticancer drugs development biotechnology company. The Company develops ovarian cancer, pancreatic cancer, gynecological cancer, and metastatic breast cancer immunotherapy drugs. CANARIABIO also produces sheep, pig, hog, poultry, and sweetened feed products.
more
bullish•ISC Co Ltd
•07 Oct 2022 06:53

KOSDAQ150 Index Rebalance Preview: Moving in the Right Direction

There could be 10 changes to the KOSDAQ150 Index in December. There are a few stocks that are close adds/deletes. The potential adds have...

Logo
658 Views
Share
bullish•CanariaBio
•05 Oct 2022 10:32

KOSDAQ 150 Rebalancing: 7 Regular Changes + 2 Special Entries

KOSDAQ 150 rebalancing in December will feature 7 regular changes and 2 special entries. This post details the screening results and the resulting...

Logo
604 Views
Share
bullish•ISC Co Ltd
•12 Jul 2022 07:00

KOSDAQ150 Index Rebalance Preview (Dec 2022): Changes Galore Early in the Review Period

One third of the way through the review period, we see 11 potential changes. The potential adds have outperformed the potential deletes and there...

Logo
641 Views
Share
x